The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mdv Vii Lp since 2015.
The trader's CIK number is 1129541.
At the time of the last reporting, Mdv Vii Lp was the 10% Owner of Adamas Pharmaceuticals Inc. (stock ticker symbol ADMS).
Also see all insider trading activities at Adamas Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ADMS | 259,118 | $4,059,293 | 0 | $0 | 0 | $0 |
| 2015 | ADMS | 0 | $0 | 223,336 | $4,552,278 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-14 | ADMS | Buy | 54,537 | 16.43 | 895,770 |
| 2016-09-15 | ADMS | Buy | 200 | 16.50 | 3,300 |
| 2016-09-16 | ADMS | Buy | 8,240 | 16.81 | 138,497 |
| 2016-09-12 | ADMS | Buy | 22,342 | 15.65 | 349,741 |
| 2016-09-13 | ADMS | Buy | 62,034 | 15.56 | 965,000 |
| 2016-09-07 | ADMS | Buy | 60,846 | 15.68 | 954,065 |
| 2016-09-02 | ADMS | Buy | 43,719 | 14.75 | 644,942 |
| 2016-09-06 | ADMS | Buy | 7,200 | 15.00 | 107,978 |
| 2015-07-10 | ADMS | Sale | 8,657 | 27.53 | 238,309 |
| 2015-07-07 | ADMS | Sale | 25,737 | 27.55 | 708,925 |
| 2015-07-08 | ADMS | Sale | 3,100 | 27.55 | 85,408 |
| 2015-06-18 | ADMS | Sale | 15,842 | 27.54 | 436,256 |
| 2015-05-28 | ADMS | Sale | 7,483 | 18.02 | 134,821 |
| 2015-05-29 | ADMS | Sale | 112,073 | 18.02 | 2,019,555 |
| 2015-05-18 | ADMS | Sale | 1,643 | 18.04 | 29,639 |
| 2015-04-10 | ADMS | Sale | 37,078 | 18.56 | 688,056 |
| 2015-03-17 | ADMS | Sale | 4,523 | 18.00 | 81,414 |
| 2015-03-18 | ADMS | Sale | 7,200 | 18.04 | 129,895 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mdv Vii Lp (10% Owner of Adamas Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.